Fred Alger Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-164,710
| Closed | -$2.96M | – | 537 |
|
|
2020
Q2 | $2.96M | Sell |
164,710
-289,175
| -64% | -$4.02M | 0.01% | 279 |
|
|
2020
Q1 | $3.24M | Sell |
453,885
-819,723
| -64% | -$10.2M | 0.01% | 240 |
|
|
2019
Q4 | $30.4M | Sell |
1,273,608
-671,400
| -35% | -$18.5M | 0.11% | 158 |
|
|
2019
Q3 | $52.2M | Buy |
1,945,008
+135,092
| +7% | +$3.79M | 0.2% | 108 |
|
|
2019
Q2 | $49.1M | Buy |
1,809,916
+77,948
| +5% | +$2.44M | 0.19% | 118 |
|
|
2019
Q1 | $60.1M | Buy |
1,731,968
+366,566
| +27% | +$10.6M | 0.24% | 96 |
|
|
2018
Q4 | $26.7M | Sell |
1,365,402
-25,083
| -2% | -$516K | 0.12% | 139 |
|
|
2018
Q3 | $37M | Buy |
1,390,485
+354,412
| +34% | +$11.6M | 0.14% | 131 |
|
|
2018
Q2 | $39.1M | Buy |
1,036,073
+137,434
| +15% | +$5.26M | 0.16% | 105 |
|
|
2018
Q1 | $29.4M | Buy |
898,639
+142,214
| +19% | +$6.24M | 0.14% | 121 |
|
|
2017
Q4 | $36.8M | Buy |
756,425
+32,694
| +5% | +$1.65M | 0.17% | 109 |
|
|
2017
Q3 | $39.1M | Buy |
723,731
+13,029
| +2% | +$765K | 0.18% | 103 |
|
|
2017
Q2 | $39.9M | Sell |
710,702
-20,313
| -3% | -$814K | 0.19% | 98 |
|
|
2017
Q1 | $28.6M | Buy |
+731,015
| New | +$23.3M | 0.14% | 113 |
|
|
2016
Q3 | – | Sell |
-95,842
| Closed | -$2.26M | – | 552 |
|
|
2016
Q2 | $2.26M | Sell |
95,842
-171,097
| -64% | -$4.22M | 0.01% | 260 |
|
|
2016
Q1 | $5.45M | Buy |
266,939
+46,709
| +21% | +$1.48M | 0.03% | 244 |
|
|
2015
Q4 | $11.3M | Sell |
220,230
-21,311
| -9% | -$1.03M | 0.06% | 166 |
|
|
2015
Q3 | $10.3M | Sell |
241,541
-148,358
| -38% | -$7.16M | 0.06% | 183 |
|
|
2015
Q2 | $17.8M | Sell |
389,899
-93,087
| -19% | -$3.74M | 0.08% | 156 |
|
|
2015
Q1 | $18.3M | Sell |
482,986
-245,623
| -34% | -$8.44M | 0.08% | 188 |
|
|
2014
Q4 | $20.6M | Buy |
728,609
+109,157
| +18% | +$3.03M | 0.1% | 175 |
|
|
2014
Q3 | $15.7M | Sell |
619,452
-2,438
| -0.4% | -$64.2K | 0.08% | 195 |
|
|
2014
Q2 | $18.1M | Sell |
621,890
-153,977
| -20% | -$3.73M | 0.09% | 193 |
|
|
2014
Q1 | $20.1M | Sell |
775,867
-55,467
| -7% | -$1.48M | 0.1% | 206 |
|
|
2013
Q4 | $21.4M | Buy |
831,334
+139,190
| +20% | +$3.38M | 0.11% | 209 |
|
|
2013
Q3 | $18.5M | Sell |
692,144
-6,025
| -0.9% | -$143K | 0.1% | 211 |
|
|
2013
Q2 | $17.2M | Buy |
+698,169
| New | +$13.9M | 0.1% | 210 |
|
Fred Alger Management's PTLA Position: Q3 2020 in Review
Fred Alger Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 164,710 shares — an estimated $2.96M sold.
Fred Alger Management first reported a position in PTLA in Q2 2013 and held it in 27 quarters. The position peaked at $60.1M in Q1 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Fred Alger Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Fred Alger Management sold 164,710 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2.96M.
- Fred Alger Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 27 quarters.
- Fred Alger Management's Portola Pharmaceuticals, Inc. position peaked at $60.1M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Fred Alger Management's 13F filing for Q3 2020, filed 13 Nov 2020.